Breadcrumb Navigation

Portrait Holger Moch

Holger Moch
Prof. Dr. med.

Direktor Institut für Pathologie und Molekularpathologie
Medizinischer Ko-Direktor (ad interim) des Universitätsspitals Zürich

Abteilungen

Kontakt

VCard

Werdegang

Aktuelle Positionen:

2022 Medical Co-Director (ad interim), University Hospital Zurich
seit 2004 Chairman, Department of Pathology and Molecular Pathology, University Hospital Zurich, Switzerland
seit 2004 Full Professor of Pathology, University Zurich, Switzerland

Ausbildung und akademische Erfahrung:

2008 – 2021 Chairman, Operational Division of Medical Diagnostics, University Hospital Zurich, Switzerland
08./09.2001 Visiting Fellow. Harvard Medical School, Department of Pathology, Massachusetts General Hospital Boston, Massachusetts, USA
1995 – 2008 Staff (Oberarzt, Leitender Arzt); Institute of Pathology, University Hospital Basel, Switzerland
1994 Research Fellow; Division of Molecular Cytometry, Department of Laboratory Medicine, University of California San Francisco; San Francisco; USA
1990 – 1993 Pathology Resident; Institute of Pathology, University Hospital Basel; Switzerland
1988 – 1990 Pathology Resident, Institute of Pathology, Charité, Berlin, Germany

Mitgliedschaften

Mitgliedschaften:

2018 WHO Classification of Tumours; 5th Edition. Editorial Board Standing Member
2015 Member of the Swiss Academy of Medical Sciences
2007 Member of the German Academy of Science “Leopoldina”

Mitgliedschaften in wissenschaftlichen Beiräten und akademischen Ausschüssen:

seit 2021 International Collaboration of Cancer Reporting, Board of Directors
seit 2021 Comprehensive Cancer Center Freiburg (CCCF); Scientific Advisory Board
seit 2020 Comprehensive Cancer Center Zurich (CCCZ), Executive Committee
seit 2017 Charles Rodolphe Brupbacher Foundation for Cancer Research; Foundation Board and Scientific Advisory Board
seit 2016 Interdisciplinary Center for Clinical Research (IZKF) of the Friedrich- Alexander University Erlangen-Nürnberg (FAU); Scientific Advisory Board
seit 2004 Cancer Registry of the Cantons Zurich, Zug, Schaffhausen, Schwyz; Executive Committee
2021 Immediate Past President of the European Society of Pathology
2019 – 2020 President of the European Society of Pathology (ESP)
2018 – 2020 Cancer Research Center Zurich, Executive Committee
2018, 2021 German Cancer Consortium (DKTK) of the German Cancer Research Center (DKFZ) Heidelberg; Scientific Advisory Board
2009-2017 German Society of Pathology (DGP); Secretary/Treasurer
2010, 2012 Charité Comprehensive Cancer Center; Scientific Advisory Board
2006 – 2009 Charles Rodolphe Brupbacher Foundation for Cancer Research; Scientific Advisory Board
2005 – 2014 Krebsforschung Schweiz; Scientific Committee (WiKo)
2004 – 2010 Swiss Group for Clinical Cancer Research (SAKK); Executive Committee
2004 – 2010 Swiss Society of Pathology (SGPath), Executive Committee

Patente

  • 08716518.9-2406 „Monoclonal human tumor-specific antibody“ (21.10.2009)
  • 08716519.7-2406 „Method of providing human tumor-specific antibodies“ (16.10.2009)
  • 10162783.4-2201 „Discrete states for use as biomarkers“ (5.7.2010)

Organisation von Konferenzen

2021 33rd European Congress of Pathology
2020 32rd European Congress of Pathology
2015 WHO-Symposium “Recent Advances in Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs”
2012 WHO-Symposium “Recent Advances in the Pathology and Genetics of Soft Tissue and Bone Tumors”
2012 Leopoldina-Symposium “Autopsie und Religion”
2009 Charles Rodolphe Brupbacher Symposium
2007 Charles Rodolphe Brupbacher Symposium